Cargando…
Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185064/ https://www.ncbi.nlm.nih.gov/pubmed/32363004 http://dx.doi.org/10.18632/oncotarget.27561 |
_version_ | 1783526693705613312 |
---|---|
author | Qu, Lihui Lu, Yingying Ying, Meike Li, Bingjue Weng, Chunhua Xie, Zhoutao Liang, Ludan Lin, Chuan Yang, Xian Feng, Shi Wang, Yucheng Shen, Xiujin Zhou, Qin Chen, Ying Chen, Zhimin Wu, Jianyong Lin, Weiqiang Shen, Yi Qin, Jing Xu, Hang Xu, Feng Wang, Junwen Chen, Jianghua Jiang, Hong Huang, Hongfeng |
author_facet | Qu, Lihui Lu, Yingying Ying, Meike Li, Bingjue Weng, Chunhua Xie, Zhoutao Liang, Ludan Lin, Chuan Yang, Xian Feng, Shi Wang, Yucheng Shen, Xiujin Zhou, Qin Chen, Ying Chen, Zhimin Wu, Jianyong Lin, Weiqiang Shen, Yi Qin, Jing Xu, Hang Xu, Feng Wang, Junwen Chen, Jianghua Jiang, Hong Huang, Hongfeng |
author_sort | Qu, Lihui |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7185064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-71850642020-05-01 Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients Qu, Lihui Lu, Yingying Ying, Meike Li, Bingjue Weng, Chunhua Xie, Zhoutao Liang, Ludan Lin, Chuan Yang, Xian Feng, Shi Wang, Yucheng Shen, Xiujin Zhou, Qin Chen, Ying Chen, Zhimin Wu, Jianyong Lin, Weiqiang Shen, Yi Qin, Jing Xu, Hang Xu, Feng Wang, Junwen Chen, Jianghua Jiang, Hong Huang, Hongfeng Oncotarget Correction Impact Journals LLC 2020-04-21 /pmc/articles/PMC7185064/ /pubmed/32363004 http://dx.doi.org/10.18632/oncotarget.27561 Text en Copyright: © 2020 Qu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Qu, Lihui Lu, Yingying Ying, Meike Li, Bingjue Weng, Chunhua Xie, Zhoutao Liang, Ludan Lin, Chuan Yang, Xian Feng, Shi Wang, Yucheng Shen, Xiujin Zhou, Qin Chen, Ying Chen, Zhimin Wu, Jianyong Lin, Weiqiang Shen, Yi Qin, Jing Xu, Hang Xu, Feng Wang, Junwen Chen, Jianghua Jiang, Hong Huang, Hongfeng Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title | Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title_full | Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title_fullStr | Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title_full_unstemmed | Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title_short | Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients |
title_sort | correction: tacrolimus dose requirement based on the cyp3a5 genotype in renal transplant patients |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185064/ https://www.ncbi.nlm.nih.gov/pubmed/32363004 http://dx.doi.org/10.18632/oncotarget.27561 |
work_keys_str_mv | AT qulihui correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT luyingying correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT yingmeike correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT libingjue correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT wengchunhua correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT xiezhoutao correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT liangludan correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT linchuan correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT yangxian correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT fengshi correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT wangyucheng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT shenxiujin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT zhouqin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT chenying correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT chenzhimin correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT wujianyong correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT linweiqiang correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT shenyi correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT qinjing correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT xuhang correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT xufeng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT wangjunwen correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT chenjianghua correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT jianghong correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients AT huanghongfeng correctiontacrolimusdoserequirementbasedonthecyp3a5genotypeinrenaltransplantpatients |